Drug
AMG 162
AMG 162 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_3
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 34 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
NCT00089674
completedphase_3
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density
NCT00325468
completedphase_3
Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only
NCT00950911
completedphase_3
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
NCT00091793
Clinical Trials (4)
Showing 4 of 4 trials
NCT00089674Phase 3
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
NCT00325468Phase 3
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density
NCT00950911Phase 3
Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only
NCT00091793Phase 3
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4